Related Experiment Video

Updated: Jan 5, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness

Colin C Pritchard1

  • 1Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.

The Canadian Journal of Urology
|October 21, 2019
PubMed

Insights

Genetic testing for DNA repair genes in advanced prostate cancer is now standard care. Mutations in genes like BRCA2 and ATM impact risk assessment and treatment decisions for patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Germline and tumor genetic testing for DNA repair genes are increasingly recommended in advanced prostate cancer guidelines.
  • Mutations in homologous DNA repair (HDR) pathway genes (e.g., BRCA2, BRCA1, PALB2, ATM) and mismatch DNA repair (MMR) genes (e.g., MSH2, MSH6) are clinically relevant.

Purpose of the Study:

  • To summarize the latest data on germline and tumor genetic testing in prostate cancer patients.
  • To highlight the clinical utility of DNA repair gene mutations for risk assessment and treatment.

Main Methods:

  • Review of presentations from the 2019 Philadelphia Consensus Conference.
  • Focus on the intersection of germline and tumor genetic testing in prostate cancer.

Main Results:

  • Damaging mutations in key DNA repair genes have emerging clinical utility.
  • Genetic testing informs risk stratification and therapeutic strategies for advanced prostate cancer.

Conclusions:

  • Genetic testing of DNA repair genes is a crucial component of standard care for advanced prostate cancer.
  • Understanding these mutations aids in personalized medicine approaches for prostate cancer management.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.1K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.2K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K